Since the economy went sideways in 2008 the stock market seems to have a tarnished image. One area of investment that is helping investors feel good about what they are doing is Biotech. The three sectors of the biotech industry that have done well and will continue to do well moving farther into the 21st century are 3D Printing, Nanotechnology, and Pharmaceuticals. Many experts predict this market will grow to several hundred billion over the decade.

The great thing about these companies is that while they create a lot of value as an investment they also create a lot of value because they save lives. Without question, biotech companies will transform the way we treat illnesses, improve the quality of health, and eventually touch every part of the way people live. The interesting thing to keep in mind if you’re considering an investment is that one of the lives this industry saves might be yours. The following companies are three of the largest in the pharmaceutical sector and the information on each of them will provide a brief introduction to what these companies are about.

Gilead Sciences

Gilead is a biopharmaceutical company focused on research. They have developed innovative medicines that fill needs that until Gilead became involved have gone unmet. Their goal is changing methods of care for people with illnesses that threaten life.

Gilead works the areas of HIV/AIDS, cancer, cardiovascular conditions, and diseases of the liver and respiratory system. Their portfolio of innovative products leads the way in some categories. These products include treatments for HIV that use a once a day pill, and a preventative oral drug that reduces the risk of getting HIV for some people.

Gilead Sciences Inc. is one of the world’s largest pharmaceutical companies and currently has a presence on six continents. They believe strongly in collaboration and work with a broad spectrum of organizations in business, government, and academia.


Founded in 1980 Amgen has since become a cutting edge independent biotech company. They believe in an approach that first focuses on biology. They study biological mechanisms in detail searching for ways to help people who suffer. Amgen works on the premise that our bodies hold the key to the cure. Their mission is to serve by following a core set of beliefs that create value for patients, staff, and stockholders. Amgen adheres to a high standard of ethical behavior in everything they do.
The list of products that Amgen has created includes Repatha, Sensipar, Enbrel, and many others. All these products help treat people with severe illnesses in over seventy countries around the world.


The stated company mission at Celgene is to deliver innovative and life-changing drugs that will help people all over the world. Improving lives are their core focus as they seek to discover, develop, and commercialize products for use fighting cancer, immune diseases, and inflammatory conditions. Celgene has created products for use in studying patients with specific incurable cancers. These illnesses include chronic lymphocytic leukemia, non-Hodgkin’s lymphoma, pancreatic cancer, and others.